Table 1.

Demographic characteristics of vaccinated subjects

		Multi-dose Vial (Thimerosalcontaining) (Lots 1, 2, & 3)	Pre-filled Syringe (Thimerosal-free)	Placebo
Number of Subjects Enrolled		823	266	268
Mean Age (years) (min, max)		38 (18,64)	38.2 (18,64)	38.2 (18,64)
Male Gender (N, %)		303 (36.8%)	103 (38.7%)	90 (33.6%)
Race* (%)
	Hispanic or Latino Ethnicity	39 (4.7%)	8 (3.0%)	5 (1.9%)
	Asian	49 (6%)	19 (7.1%)	15 (5.6%)
	Black or African-American	101 (12.3%)	33 (12.4%)	31 (11.6%)
	White	667 (81.0%)	217 (81.6%)	219 (81.7%)
	Other	23 (2.8%)	1 (0.4%)	8 (3.0%)
Reason for Termination (%)
	Lost to follow-up	3 (0.4%)	1 (0.4%)	1 (0.4%)
	Voluntary withdrawal	0 (0%)	0 (0%)	1 (0.4%)

^*Subjects in the study could be counted in more than one race.